Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortBiologic injection for arthritis, IBD and psoriasis.IV anti-TNF biologic for Crohn's and arthritis.
Body systemJoints & ImmunityJoints & Immunity
Drug classTNF inhibitorsTNF inhibitors
SupplyPrescription onlyPrescription only
Main usesRheumatoid and psoriatic arthritis, Ankylosing spondylitis, Crohn's disease and ulcerative colitis, Psoriasis, Hidradenitis suppurativaCrohn's disease, Ulcerative colitis, Rheumatoid arthritis, Ankylosing spondylitis, Psoriasis
How it worksMops up a key inflammation signal.Blocks a key inflammation signal.
Starts working——
Half-lifeAbout 2 weeks8–10 days
Typical adult dose40 mg under the skin every other week (some conditions start higher or go weekly).5 mg/kg IV at weeks 0, 2 and 6, then every 8 weeks.
FormsPre-filled pen, Pre-filled syringeIV infusion, Subcutaneous pen
Common side effectsInjection-site reactions, Upper respiratory infections, HeadacheInfusion reactions, Headache, Upper respiratory infections
Serious side effectsSerious infections including TB reactivation, Lymphoma (rare), Demyelination, Heart failure worseningSerious infections and TB, Lymphoma (rare), Liver injury
Don't take if——
Alcohol——
PregnancyUse with cautionOften continued into pregnancy for IBD; baby's live vaccines may be delayed.Use with cautionOften continued with planning; affects the baby's early live vaccines.
Breastfeeding——
In use since20021998
Brand namesUnited States: Humira, Hadlima, Hyrimoz, YuflymaUnited Kingdom: Humira, Amgevita, Imraldi, YuflymaIndia: Exemptia, AdfrarUnited States: Remicade, Inflectra, ZymfentraUnited Kingdom: Remicade, Remsima, InflectraIndia: Remicade, Infimab
Legal status——
ATC codeL04AB04L04AB02

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker